Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0.0 | $50.0K | $3,663.0K | $13.4M | $36.1M | $66.0M | $97.0M | $152.3M | $211.4M | $247.1M | $288.7M | $263.9M | $367.0M | $463.8M | $563.8M | $738.2M | $904.4M | $1,098.8M | $1,305.3M | $1,697.1M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Insulet Corporation's last 12-month Revenue is $1,812.6M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Insulet Corporation's Revenue growth was 16.4%. The average annual Revenue growth rates for Insulet Corporation have been 23.7% over the past three years, 21.2% over the past five years.
Over the last year, Insulet Corporation's Revenue growth was 16.4%, which is higher than industry growth of 0.1%. It indicates that Insulet Corporation's Revenue growth is Good.